Juvenile Paget disease: A Patient Guide

Juvenile Paget Disease (JPD) is an ultra-rare, inherited condition that changes how a child’s body builds and maintains its skeleton. In a healthy body, bone is constantly being broken down and replaced in a balanced, steady cycle. In a child with JPD, this balance is lost due to a genetic deficiency in a protein called osteoprotegerin (OPG), which normally acts as a “brake” on the cells that break down bone ^[1]. Without this vital regulator, bone breakdown and rebuilding occur at a rapid pace—a state known as high-turnover remodeling—which results in bone that is expanded but structurally weak ^[2].

Because the condition is systemic, it behaves as more than just a skeletal disorder. Over time, the rapid remodeling can lead to physical changes such as leg bowing, frequent fractures, and bone pain ^[3]. The same biological processes can also impact other parts of the body, making early and comprehensive diagnosis essential ^[4]. While bone manifestations are the most common, some children experience “extraskeletal” complications, such as progressive hearing loss, retinal changes in the eyes, or very rarely, changes in the blood vessels ^[5]. Monitoring for these possible complications is guided by a specialist based on the child’s individual symptoms and clinical findings.

Managing JPD is a long-term commitment that focuses on restoring balance to the skeleton. Treatment typically involves a class of medications called bisphosphonates, which help slow down the overactive bone-breaking cells to reduce pain and improve bone strength ^[6]. Because these treatments are powerful, they require expert management, particularly regarding the body’s mineral balance. It is critical that the treating team closely manages a child’s calcium and vitamin D levels before and after treatment to prevent blood calcium from dropping to dangerously low levels ^[7].

Given the rarity and complexity of the disease, no single doctor can provide all the necessary care. Families are best supported by a core team led by a pediatric metabolic bone specialist, who will coordinate with clinical geneticists and, when indicated, audiologists, ophthalmologists, and rehabilitation specialists ^[2]. While the diagnosis presents significant challenges, modern, individualized treatment approaches aim to help children with JPD improve their skeletal health and preserve their mobility ^[8].